2024 Journal Article Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancerMartini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Douglas A (2024). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 485 (4), 723-728. doi: 10.1007/s00428-023-03643-1 |
2024 Journal Article Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristicsRoberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482 |
2024 Journal Article Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkersLogan, Jessica M., Martini, Carmela, Sorvina, Alexandra, Johnson, Ian R. D., Brooks, Robert D., Caruso, Maria C., Huzzell, Chelsea, Moore, Courtney R., Karageorgos, Litsa, Butler, Lisa M., Tewari, Prerna, Prabhakaran, Sarita, Hickey, Shane M., Klebe, Sonja, Samaratunga, Hemamali, Delahunt, Brett, Moretti, Kim, O’Leary, John J., Brooks, Douglas A. and Ung, Ben S.-Y. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data, 11 (1) 852, 1. doi: 10.1038/s41597-024-03696-0 |
2024 Journal Article Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenSamaratunga, Hemamali, Delahunt, Brett, Olsson, Mats, Aly, Markus, Egevad, Lars and Yaxley, John (2024). Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen. Pathology, 56 (7), 1059-1061. doi: 10.1016/j.pathol.2024.05.013 |
2024 Journal Article Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyEgevad, Lars, Micoli, Chiara, Delahunt, Brett, Samaratunga, Hemamali, Orrason, Andri Wilberg, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. Virchows Archiv, 484 (6), 995-1003. doi: 10.1007/s00428-024-03810-y |
2024 Journal Article Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyEgevad, Lars, Micoli, Chiara, Samaratunga, Hemamali, Delahunt, Brett, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. European Urology Oncology, 7 (2), 213-221. doi: 10.1016/j.euo.2023.11.002 |
2024 Journal Article UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian populationDesai, Devang, Harrison, William, Raveenthiran, Sheliyan, Samaratunga, Hemamali and De Win, Gunter (2024). UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population. Translational Andrology and Urology, 13 (3), 423-432. doi: 10.21037/tau-23-549 |
2024 Journal Article Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsSamaratunga, Hemamali, Egevad, Lars, Yaxley, John, Perry-Keene, Joanna, Le Fevre, Ian, Kench, James, Matsika, Admire, Bostwick, David, Iczkowski, Kenneth and Delahunt, Brett (2024). Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients. Pathology, 56 (1), 33-38. doi: 10.1016/j.pathol.2023.10.005 |
2023 Journal Article Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomographyVis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010 |
2023 Journal Article Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spreadSorvina, Alexandra, Martini, Carmela, Prabhakaran, Sarita, Logan, Jessica M., S-Y. Ung, Benjamin, Moore, Courtney, Johnson, Ian R.D., Lazniewska, Joanna, Tewari, Prerna, Malone, Victoria, Brooks, Robert D., Hickey, Shane M., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Doug A. (2023). Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology, 55 (6), 792-799. doi: 10.1016/j.pathol.2023.05.004 |
2023 Journal Article Web-grading—a tool to test personal grading of renal and prostate cancerKristiansen, Glen, Schmid, Matthias, Egevad, Lars, Samaratunga, Hemamali, Varma, Murali, Inam, Kaan, Thiesen, Hans-Jürgen, Delahunt, Brett and Dai, Yulin (2023). Web-grading—a tool to test personal grading of renal and prostate cancer. APMIS, 131 (10), 528-535. doi: 10.1111/apm.13347 |
2023 Journal Article Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancerMartini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S-Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali, Brooks, Douglas A. and kConFab Consortium (2023). Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 1-1. doi: 10.1007/s00428-023-03666-8 |
2023 Journal Article Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?Samaratunga, Hemamali, Egevad, Lars and Delahunt, Brett (2023). Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?. Pathology, 56 (1), 141-142. doi: 10.1016/j.pathol.2023.08.005 |
2023 Journal Article Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRISamaratunga, Hemamali, Hussey, David, Le Fevre, Ian K., Egevad, Lars, Sarikwal, Anubhav, Carim, Humza and Delahunt, Brett (2023). Florid basal cell hyperplasia mimics high PI-RADS score prostate cancer on mpMRI. Pathology, 56 (3), 413-415. doi: 10.1016/j.pathol.2023.07.011 |
2023 Journal Article Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopyUrquhart, Aaron J., Del Vecchio, Sharon J., Lukas, Darren, Ellis, Robert J., Humphries, Tyrone L.R., Ng, Keng Lim, Samaratunga, Hemamali, Galloway, Graham J., Gobe, Glenda C., Wood, Simon T. and Mountford, Carolyn E. (2023). Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy. Advances in Biomarker Sciences and Technology, 5, 68-75. doi: 10.1016/j.abst.2023.08.001 |
2023 Journal Article Not all tumour necrosis is granular necrosisSamaratunga, Hemamali, Egevad, Lars and Delahunt, Brett (2023). Not all tumour necrosis is granular necrosis. Pathology, 55 (6), 903-904. doi: 10.1016/j.pathol.2023.03.019 |
2023 Journal Article International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2 : grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomasPaner, Gladell P., Kamat, Ashish, Netto, George J., Samaratunga, Hemamali, Varma, Murali, Bubendorf, Lukas, van der Kwast, Theodorus H., Cheng, Liang and the Members of the ISUP Bladder Tumor Consensus Panel (2023). International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2 : grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. American Journal of Surgical Pathology, 48 (1), e11-e23. doi: 10.1097/pas.0000000000002077 |
2023 Journal Article Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1Logan, Jessica M., Hopkins, Ashley M., Martini, Carmela, Sorvina, Alexandra, Tewari, Prerna, Prabhakaran, Sarita, Huzzell, Chelsea, Johnson, Ian R. D., Hickey, Shane M., Ung, Ben S.-Y., Lazniewska, Joanna, Brooks, Robert D., Moore, Courtney R., Caruso, Maria C., Karageorgos, Litsa, Martin, Cara M., O’Toole, Sharon, Bogue Edgerton, Laura, Ward, Mark P., Bates, Mark, Selemidis, Stavros, Esterman, Adrian, Heffernan, Sheena, Keegan, Helen, Ní Mhaolcatha, Sarah, O’Connor, Roisin, Malone, Victoria, Carter, Marguerite, Ryan, Katie ... Brooks, Douglas A. (2023). Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1. Cancers, 15 (12) 3215, 1-12. doi: 10.3390/cancers15123215 |
2023 Journal Article International opinions on grading of urothelial carcinoma: a survey among European Association of Urology and International Society of Urological Pathology membersBeijert, Irene J., Cheng, Liang, Liedberg, Fredrik, Plass, Karin, Williamson, Sean R., Gontero, Paolo, Ribal, Maria J., Babjuk, Marko, Black, Peter C., Kamat, Ashish M., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Masson-Lecomte, Alexandra, Rouprêt, Morgan, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Shariat, Shahrokh F., Mostafid, A. Hugh, Varma, Murali, Shen, Steven, Burger, Maximilian, Tsuzuki, Toyonori, Palou, Joan, Compérat, Eva M., Sylvester, Richard J., van der Kwast, Theo H., van Rhijn, Bas W.G. and Downes, Michelle R. (2023). International opinions on grading of urothelial carcinoma: a survey among European Association of Urology and International Society of Urological Pathology members. European Urology Open Science, 52, 154-165. doi: 10.1016/j.euros.2023.03.019 |
2023 Journal Article Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imagingSamaratunga, Hemamali, Egevad, Lars, Yaxley, John W., Johannsen, Shulammite, Le Fevre, Ian K., Perry-Keene, Joanna L., Gianduzzo, Troy, Chabert, Charles, Coughlin, Gregory, Parkinson, Robert, Kua, Boon, Yaxley, William and Delahunt, Brett (2023). Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging. American Journal of Surgical Pathology, 47 (6), 701-708. doi: 10.1097/pas.0000000000002042 |